Jessica Federer

Board Member at Angelini Ventures

Speaker

Ms.Federer is an independent board member for public and private companies, and serves on the board of Angelini Ventures, a new fund investing in biotech and life sciences companies. Previously, she was the Chief Digital Officer for one of the world’s largest life sciences companies, leading the enterprise-wide digital transformation for Bayer A.G. across the Pharmaceutical, Consumer Care, Crop Science, and Animal Health businesses. She is an external senior advisor for McKinsey and has advised both Fortune Global 100 companies and industry disrupting start-ups. During the pandemic, she joined Europe’s fastest growing digital health company as Managing Director, building a U.S. team and expanding into decentralized clinical trials for international Covid-19 vaccine studies. Federer chairs the Health of Women Investor Summit at the New York Stock Exchange, convening investors representing trillions in investment capital, and serves on both the Yale Ventures Blavatnik Advisor board and the Yale Institutional Review Board. She was on the United Nations International Telecommunications Union m-powering development advisory board and the BHP Science and Technology Advisory Board. She is recognized as a 2023 “Icon” by Rock Health, a Health Equity Champion, and one of the top 100 CDOs. Federer began her public health career at the Agency for Healthcare Research and Quality in the US Department of Health and Human Services. She earned a Bachelor of Science from the George Washington University, and a Master of Public Health from Yale.